Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 11846301

Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Pediatr Hematol Oncol
Publication date
2001 May
First author
Breitfeld PP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Pediatr Hematol Oncol. 2001 Aug-Sep;23(6):334-7. doi: 10.1097/00043426-200108000-00002.
    note
    Source null
    related pmid
    11563765
    relationship
    Comment in

Authors and identifiers

  1. name
    Breitfeld PP
    type
    Author
  2. name
    Lyden E
    type
    Author
  3. name
    Raney RB
    type
    Author
  4. name
    Teot LA
    type
    Author
  5. name
    Wharam M
    type
    Author
  6. name
    Lobe T
    type
    Author
  7. name
    Crist WM
    type
    Author
  8. name
    Maurer HM
    type
    Author
  9. name
    Donaldson SS
    type
    Author
  10. name
    Ruymann FB
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Breitfeld PP
    type
    Author
  2. name
    Lyden E
    type
    Author
  3. name
    Raney RB
    type
    Author
  4. name
    Teot LA
    type
    Author
  5. name
    Wharam M
    type
    Author
  6. name
    Lobe T
    type
    Author
  7. name
    Crist WM
    type
    Author
  8. name
    Maurer HM
    type
    Author
  9. name
    Donaldson SS
    type
    Author
  10. name
    Ruymann FB
    type
    Author
bibliography ids
  1. nci-bib-ecdb703b35cfbe41b724105b
book metadata
content sha256
7a7f4b2d922e2edfd6c80c88478beb3281e2afb9daf169cdda83104c6967e216
document type
citation
dois
  1. 10.1097/00043426-200105000-00010
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:11846301
immutable id
pubmed:11846301@7a7f4b2d922e2edfd6c80c88478beb3281e2afb9daf169cdda83104c6967e216
journal
abbreviation
J Pediatr Hematol Oncol
issn electronic
Source null
issn print
1077-4114
issue
4
name
Journal of pediatric hematology/oncology
nlm unique id
9505928
pages
225-33
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Pediatr Hematol Oncol. 2001 Aug-Sep;23(6):334-7. doi: 10.1097/00043426-200108000-00002.
    note
    Source null
    related pmid
    11563765
    relationship
    Comment in
outcomes validated
false
pmid
11846301
provenance
batch id
d4e82e28940c878dd0a2
provider
NCBI PubMed ESummary
record sha256
0068b8f2289934d4d6d4169c382eb28bdb2e4b733861daa00fd344d977befad7
response sha256
257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
retrieved at
2026-09-09T23:45:44.017762+00:00
publication date
display
2001 May
precision
month
year
2001
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase II
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/11846301/
title
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.

Preserved source evidence · Not medical advice